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SPECIAL SERIES: CANCER CLASSIFICATION SYSTEMS

review articles

Evolution of the Cancer Registrar in the Era
of Informatics

abstract

The cancer registrar reports accurate, complete, and timely abstracted cancer data to various healthcare
agencies. The data are used for understanding the incidence of cancer, evaluating the effectiveness of public
health efforts in the prevention of new cases and improving patient care outcomes and survival. There are
increasing demands placed on registrars for additional data points with real-time submission to reporting
agencies. To that end, registrars are increasing the use of informatics to meet the demand. The purpose of this
article is the role of the registrar in the collection and reporting of critical cancer data and how registrars are
currently using informatics to enhance their work. This article describes how informatics can be leveraged in the
future and how registrars play a vital role in meeting the increasing demands placed on them to provide timely,
meaningful, and accurate data for the cancer community.

Kelly W. Merriman, MPH, PhD, CTR1; Ronda G. Broome, MS, MSHMI, CTR2; Giordana De Las Pozas, MD1; Lisa D. Landvogt, BA, CTR3;
Ying Qi, MS, CTR4; and Judith Keating, CTR5
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BACKGROUND: HISTORY OF THE CANCER
REGISTRY PROFESSION
A cancer registry is an information system that allows
for the collection, management, and analysis of information on patients with cancer.1 The ﬁrst modern
hospital–based cancer registry was established at
Yale-New Haven Hospital in Connecticut in 1926, and
the ﬁrst state central registry was established in
Connecticut in 1935 (Table 1).2
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In 1956, the American College of Surgeons (ACoS) required a cancer registry for approved cancer programs
in the United States. In 1971, the National Cancer Act
budgeted monies to the National Cancer Institute (NCI)
for research, detection, and treatment of cancer, and in
1973, the SEER Program of NCI established the ﬁrst
national cancer registry. Finally, in October 1992,
Congress established a National Program of Cancer
Registries (Public Law 102-515, The Cancer Registries
Amendment Act). There are three types of registries:
hospital, population-based central registry, and special
purpose registries.3 Most registries include reports of all
malignant cancers, except for nonmelanoma skin
cancers. Reported data can come from various medical
facilities, including hospitals, physicians’ ofﬁces, and
pathology laboratories. The data are collected for multiple reasons, including understanding the incidence of
cancer, researching patterns of cancer treatment, and
improving patient care outcomes and survival.4
Abstracting cancer data is a highly skilled profession
that requires comprehension of cancer information,

and appropriately coding those data and processing
them into an international format. Possessing this
knowledge allows cancer registries to provide data
users with the necessary facts for that facility, time
period, and speciﬁc cancer. The speciﬁcations of the
coding process are critical for the quality of the output
based on the increased knowledge and continuing
education of the cancer registrar. Often, registrars
serve as data subject matter experts and are responsible for bridging the gap between clinicians and
statisticians. The registrar collects the data and ensures the accuracy, completeness, and quality of the
data. They comply with state and federal laws for
reportable cases and maintain the database that
houses the cancer program’s cancer cases. The ability
to follow and report the patient’s cancer journey from
diagnosis through treatment and survival information
in a cancer registry system is one of the many core
strengths of the cancer registry.
The cancer registry profession has been valued since
the early 20th century, gaining further recognition and
prominence through the efforts of ACoS to include it as
a required component of the accredited cancer program. In addition, the National Cancer Registrars
Association (NCRA) has helped to further promote the
registry profession through NCRA’s Council of Certiﬁcation by creating the certiﬁed tumor registrar (CTR)
credential in the 1980s.2 In the 21st century, the CTR
profession has increased complexity because of the
challenges of locating patient information from multiple sources and abstracting the required information
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CONTEXT
Key Objective
To describe how informatics can be leveraged by cancer registrars to capture essential cancer data.
Knowledge Generated
Informatics is currently being used by cancer registrars for case ﬁnding and follow-up. In the future, entering data into
structured ﬁelds in the Electronic Health Record and other initiatives will allow for more timely and accurate data reported to
the state and National Cancer Database.
Relevance
The data that are abstracted by the cancer registrar have signiﬁcant clinical relevance for multiple reasons. First, the data
collected provide a census of cancer cases that can be used to deﬁne cancer incidence and mortality (eg, American Cancer
Society Facts and Figures Reports). Second, the data are used to update staging versions over time. Finally, the data are
used to improve patient care outcomes and survival.

into the growing number of deﬁned data ﬁelds. Cancer
registrars must abide by the national standards of reporting
accurate, complete, and timely cancer data to various
healthcare agencies.5 The purpose of this article will be to
review how registrars leverage informatics to meet the everincreasing demand of additional variables and report this
information in real time to numerous external reporting
agencies. In addition, the evolving role of the registrar will
be explored.
CURRENT WORK OF THE REGISTRAR AND INFORMATICS

number of changes in reporting data variables being required for submission. New data ﬁelds were created in
response to the American Joint Committee on Cancer
(AJCC) 8th edition staging manual and included 137 sitespeciﬁc data items (SEER SSDI). These additional data
items further enhanced the value of registry data, yet also
increased the complexity and time required to abstract new
cancer cases. Thus, it is critical to leverage informatics to
help with the registrars’ processes, beginning with follow-up
data from the Electronic Health Record (EHR) and the
institutional data warehouse (IDW).

By law, hospital registrars report cancer cases to their state
cancer registry within 6 months of their facility’s date of ﬁrst
contact with a patient. In addition, for hospitals that are
voluntarily accredited by Commission on Cancer (CoC), the
shift to concurrent abstracting is changing the timeliness of
reporting. In the past, registrars were required to submit to
the National Cancer Database (NCDB) on an annual basis.
Registrars are now focusing on abstracting in phases
(concurrent abstracting) after certain time periods of the
patient’s cancer care. Finally, the 2018 data standards for
collection of cancer registry data saw an unprecedented

Information collected during follow-up includes patient vital
status through the lifetime of the patient. Cancer registrars
perform, at minimum, annual follow-up for each patient
with cancer as this provides accurate and updated survival
information. Because of the recent advances in the electronic exchange of information, automated follow-up takes
full advantage of electronic resources and reduces the time
and labor expended in data collection. The data include
using structured ﬁelds for completed appointments for
physical visits, the use of the billable service date as the last
contact date, and the latest encounter date in the EHR.

TABLE 1. Timeline of Cancer Registry or Profession
1926—First hospital-based cancer registry at Yale in New Haven, Connecticut
1935—First state central registry was established in Connecticut
1956—American College of Surgeons required cancer registry for approved
cancer programs
1973—First national cancer registry established by National Cancer Institute
within the SEER Program
1983—National Tumor Registrars Association established certiﬁed tumor
registrar credential
1992—Congress established the Cancer Registries Amendment Act
1993—National Tumor Registrars Association changed to National Cancer
Registrars Association
2017—Health Information Technologists and Medical Registrars standard
occupational code established

Another challenge for registrars is case ﬁnding, which involves identifying all the cancer cases that are reportable to
the state of all patients seen at the facility. Reportable
cancer cases are those cases that are required to be
submitted to state registries and the NCDB. As the demand
for more real time reporting increases, a registrar cannot
possibly review all their cases manually in the larger cancer
facilities. Thus, it is imperative to leverage additional tools to
extract information for case ﬁnding and if possible, autopopulate the database from identiﬁed variables in the EHR.
This ranges from querying the IDW for identifying cases
using billing data and the use of Natural Language Processing software.
Natural language processing (NLP) allows users to convert
free text into machine readable, structured data, which are
a large part of the data in EHRs currently today. The main
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FIG 1. Screenshot of commercialized tumor registry system pathology data in CAP
format.

data leveraged using NLP are College of Pathology templates (CAP) from the EHR to derive the International
Classiﬁcation of Diseases for Oncology (ICD-O) codes for
site and histology as well as diagnosis date and AJCC stage.
Figure 1 demonstrates how registrars can autopopulate
ﬁelds from a CAP protocol into a commercialized Tumor
Registry system after verifying the information, in this example, an astrocytoma of the frontal lobe. This example
demonstrates how a registrar’s job may become more of
quality assurance than manually entering data into a database. Additionally, some site-speciﬁc factors can be
determined such as Estrogen and Progesterone Receptors
status for breast cancer.
One can also apply NLP to scanned documents using
optical character recognition (OCR), which allows registrars
to increase efﬁciency by using informatics tools. For example, a major challenge in the cancer registry at larger
cancer hospitals such as MD Anderson Cancer Center is
that more than half of the new patients managed at the
facility have received previous treatment, relapsed (nonanalytical), and present with a large volume of outside
scanned records. MD Anderson’s information technology
team was able to develop an OCR NLP pipeline for text
retrieval and cancer information extraction and summarization. First, the resolution of the image of a scanned
document is enhanced and text is retrieved from the image
using OCR. Then, the pipeline uses clinical language annotation, modeling, and processing (CLAMP) as the primary
NLP component for named entity recognition against OCRed text (Fig 2). It is based on a machine learning model
(conditional random forest), speciﬁcally trained on clinical

data. The development of CLAMP Cancer Modules involved
building cancer-speciﬁc NLP components and extending
CLAMP interface that allows end users to customize different components into an NLP pipeline for their speciﬁc
needs.6 Some additional rules are built post-NLP to extract
event dates related to named entities and to suppress
noises from nonpatient data such as genetic test reference
data or patient’s family cancer history. Finally, the extracted
cancer diagnosis, diagnosis date, and treatment information are organized into oncology speciﬁc data folders and
presented to the end user in a web application. This process
has matured, and there now exists a search engine that is
EHR embeddable. The application also has the capacity to
ingest very large volumes of either PDF or electronically
transferred documents, returning a detailed list of cancer
diagnoses, stage, genomic information, and treatment information with dates for rapid review. The platform tags the
location within the source documents for rapid validation of
the information in a side-by-side window format. This tool
can improve the overall efﬁciency of data abstraction and
processing for registrars. For example, MD Anderson’s
registrars’ review of outside scanned documents on nonanalytic cases was reduced from approximately 45 to 15
minutes per cancer case. Registrars have been actively
involved in this work, helping to improve the NLP accuracy
and the time it takes to review a cancer case with numerous
scanned documents.
THE FUTURE OF THE REGISTRAR AND INFORMATICS
Some data elements in the EHR, such as demographics
and tumor characteristics, are also needed in the registry
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FIG 2. OCR/NLP diagram. NLP, natural language processing; OCR, optical
character recognition.

Tensorflow Keras
doc-classify

NLP

Database Storage

system. To avoid duplication of effort, there is a need for
interoperability between the two systems. Interoperability is
the ability of computer systems or software to exchange and
make use of information.7 Interoperability allows for delivery
of the right information at the right time to the right place. To
improve efﬁciency and accuracy of data collection in the
registry using interoperability, there is a need to leverage the
information in the EHR and directly link this information into
the registry software. The current method of manual extraction of patient information from EHRs and manually
entering this information into the registry software is not
sustainable.
One data standard effort that has been developed is Health
Level Seven (HL7) to empower global health data interoperability within EHRs.8 Just like in the cancer registry with
usage of coding manuals, HL7 provides a protocol of
speciﬁcations in addition to a framework of standards for
the exchange, integration, sharing, and retrieval of electronic health information, which is what we need.9 Electronic data sharing between healthcare organizations
through interoperable processes would enable coordinated
care, decrease costs, and improve patient outcomes.7 If
EHRs were able to interact and information was shared with
the registry software, then the registrar’s role would become
more of quality assurance of the data. Hopefully, interoperability will also aid the registrar in obtaining treatment
information from outside facilities, since patients often
receive fragmented treatment at multiple facilities. In addition, obtaining detailed outcome information such as
recurrence will improve with an increase in interoperability
between numerous EHRs.
One critical role that most hospital registrars fulﬁll is the
Rapid Quality Reporting System (RQRS) for CoC-accredited
facilities. The application of RQRS allows for real-clinicaltime reporting of quality measures using registry data to
actively monitor treatment information.10 The prospective
dashboard that is provided for CoC facilities displays

OCR NLP Document Viewer

information regarding treatment and quality measures as
documented in the registry. This reporting provides insight
into the treatment of the patient with cancer at the facility
and allows for real-time alerts if patients are not being
treated in a speciﬁc time frame.10 This level of insight allows
the cancer program to assess their evidence-based cancer
care practice and identify patients who do not receive the
anticipated care during the predetermined time frame to
allow for intervention. A fundamental change that occurred
in late 2020 is the RCRS with NCDB as a response to having
timelier data.11 The new IT platform will combine and replace the best of RQRS (at least quarterly) and NCDB
(annually) Call for Data and use one portal for all submissions. More importantly, the reporting will be done in
phases and along the continuum of the natural course of a
patient’s cancer. The long-term goal of NCDB with this
change in platform is an emphasis on timeliness and agility
with an improvement in quality monitoring and quality
improvement.11 The greatest challenge in supporting this
initiative depends on the healthcare professional entering
data in the EHR-supported template structure, so the information can be converted and ingested by the registry
software. This requires that the registrar can communicate
to technology specialists exactly where the data are located
within the EHR.
Furthermore, the registrar is a crucial member of the cancer
program. The role has evolved from simply inputting data in
the software to creating and generating reports that provide
insight into the cancer program. This insight includes, but
not limited to, in- and out-migration of the patient with
cancer for treatment and services and identifying the top
cancer sites served at the facility. Cancer registrars are
needed in precision medicine with real-world data abstraction, government programs that use the data, software
vendors that are used to collect the data, and on task forces
that create and maintain the standards for data collection.
Using knowledge, experience, and skills, the registrar is
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2019-2023
Strategic Management Plan
VISION

FIG 3. NCRA strategic management

MISSION

plan.
DEFINING THE FUTURE

Curated data ... advancing outcomes
Empower and advance registry professionals through innovations in education, advocacy,
credentialing, and strategic partnerships.
We visualize a future where there will be the increasing demands for more real-time, pertinent
curated health data from an ever-growing and evolving matrix of patient information.
We believe that the integral role of the registrar will require ever-increasing responsibility and
skills to oversee, analyze, and construct relevant linkages in the development of data pipelines.
We believe the role of the registrar will require an increasing need for nimbleness, use of
technology, and a voice throughout the continuum of the data pipeline in order to have a
positive impact on quality of care.
We imagine a future with a continually increasing survivorship, expanded patient support, and
broadened public information networks leading to healthier communities.

prepared to collaborate and generate high output and highquality data to assist in the ﬁght against cancer.
DISCUSSION
As described in this paper, cancer registrars are continuing
to leverage informatics in their everyday workﬂow. Registrars have the knowledge, experience, and skills to accurately abstract the cases. They are leading the way in how
informatics can be applied in the cancer registry data
collection process. Most cancer registry systems can now
integrate with data that reside in the EHR as structured
data. The registrar can optimize the structured data and
work on prepopulating certain data elements. For example,
AJCC staging of the cancer is data element that should be
recorded by the clinician before the initiation of treatment or
during the cancer journey. If this and other key data elements were stored in EHRs as structured data elements,
registrars would be able to pull this into the registry system,
which would prevent the manual re-entering of this
information.
To generate real-time data, the information should be
readily extracted from the EHR, but often it is not. This is
primarily due to data not being entered into the structured
data ﬁelds that are available in these systems. In an editorial
response in 2016, Evans et al12 state that cancer stage
should be determined and documented by providers in the
EHR, but this often is not done or appears in free text rather
than the important structured data ﬁelds that are readily
available in most EHRs. They commend the work that
Warner et al13 did with extracting cancer stage information
from narrative EMR data using NLP, but they advocate that
with such important data, it must be discrete, structured
data. Reasonable accuracy is not good enough for such
important data items, since staging is such an important
indicator for determining treatment and survival outcomes.
In addition, registrars are being asked to automate data out
of the EHR but struggle with what is the correct stage when
there are multiple responses for the same patient’s cancer

stage. It takes the registrar longer to determine the correct
stage from the numerous responses than to stage the
cancer themselves.
Automation from EHRs to cancer registry systems cannot
happen unless providers (or their representatives) are
willing to enter data into structured data ﬁelds. Unfortunately, clinicians are often pressed for time and it is not the
best use of their time to enter data discretely in structured
ﬁelds.14,15 In addition, it has been demonstrated that the
amount of time that is required for documentation has
increased provider frustration with using EHRs. Rosenbloom et al16 describe the tension between the need for
structure for the second use of data downstream and
ﬂexible documentation for providers. Busy providers value
ﬂexibility and efﬁciency, whereas users downstream often
value structure and standardization. The tension between
providers and end users differs because the goals are
different between the two groups. Providers’ goals range
from reports of their clinical impressions and actions to
justifying the level of service billed and creating a legal
record in the case of litigation. However, end users such as
registrars require structure and standardization, which
limits the providers’ ability to describe nuances in a patient’s care.16 One potential solution to help busy physicians
document in the EHR is to use registrars to input clinical
stage information into the EHR and the physician would just
review and sign off on the stage,12 since registrar staging is
considered the gold standard compared with NLP.
Finally, one important initiative led by ASCO and a group of
collaborators, including oncologists, researchers, and other
experts, in 2018 is mCODE: Minimal Common Oncology
Data Elements. The initiative is providing a common data
language and a data model for interoperability across
numerous EHRs throughout the United States. More importantly, it is developed and maintained by its users in a
highly collaborative environment.17 As mCODE grows, the
interoperability capabilities will also work for cancer registry
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systems, and registrars will be able to pull the critical data
into their systems for reporting purposes.
In conclusion, a change in workﬂow can create resistance;
however, registrars must be willing to embrace new processes and technology. Informatics must become a part of
registry abstraction, and registrars play a vital role in that
process. For example, they will be needed from the initial
build as the subject matter experts in the rules and standards for each data ﬁeld to the curation of the imported data
(Fig 3). The profession will require additional education for
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